# Medicus Pharma Ltd.: filings

MDCX · Nasdaq · CIK 1997296 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mdcx.md) · [Financials](/companies/mdcx/financials.md) · [Filings](/companies/mdcx/filings.md) · [Insiders](/companies/mdcx/insiders.md)

## Reports and events: 59 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (424B3 92, 4 57, 8-K 34, 253G2 23, 3 16, EFFECT 12, 3/A 10, F-1/A 9, CORRESP 8, 6-K 6, DRS 6, SCHEDULE 13G/A 6, UPLOAD 6, 10-Q 5, S-1 5, SCHEDULE 13G 5, POS AM 4, DEF 14A 3, PRE 14A 3, QUALIF 3, 10-K 2, 10-K/A 2, 1-A POS 2, 424B4 2, ARS 2, D 2, S-3 2, 144 1, 1-A 1, 1-A/A 1, 253G1 1, 424B5 1, 8-A12B 1, 8-K/A 1, CERT 1, D/A 1, F-1 1, F-X 1, PRER14A 1, S-8 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 16:16 ET | [DEF 14A](/filings/0001062993-26-005627.md) | Proxy statement, period 2026-12-02 | 0001062993-26-005627 |
| 2026-10-23 | 17:15 ET | [8-K](/filings/0001062993-26-005528.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-26-005528 |
| 2026-10-16 | 16:55 ET | [8-K](/filings/0001062993-26-005382.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001062993-26-005382 |
| 2026-10-07 | 16:05 ET | [8-K](/filings/0001062993-26-005226.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-26-005226 |
| 2026-09-14 | 16:39 ET | [SCHEDULE 13D](/filings/0000950142-26-002546.md) | Ownership report, active investor | 0000950142-26-002546 |
| 2026-09-14 | 08:05 ET | [8-K](/filings/0001062993-26-004906.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001062993-26-004906 |
| 2026-09-11 | 08:00 ET | [8-K](/filings/0001062993-26-004898.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001062993-26-004898 |
| 2026-09-03 | 08:00 ET | [8-K](/filings/0001062993-26-004806.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001062993-26-004806 |
| 2026-08-12 | 17:19 ET | [10-Q](/filings/0001062993-26-004230.md) | Quarterly report, period 2026-06-30 | 0001062993-26-004230 |
| 2026-06-04 | 16:30 ET | [8-K](/filings/0001062993-26-003060.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001062993-26-003060 |
| 2026-05-27 | 16:45 ET | [8-K](/filings/0001062993-26-002900.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001062993-26-002900 |
| 2026-05-14 | 16:06 ET | [10-Q](/filings/0001062993-26-002629.md) | Quarterly report, period 2026-03-31 | 0001062993-26-002629 |
| 2026-05-04 | 19:00 ET | [DEF 14A](/filings/0001062993-26-002277.md) | Proxy statement, period 2026-06-03 | 0001062993-26-002277 |
| 2026-04-29 | 17:21 ET | [10-K/A](/filings/0001062993-26-002212.md) | Annual report, amended, period 2025-12-31 | 0001062993-26-002212 |
| 2026-04-24 | 17:27 ET | [8-K](/filings/0001062993-26-002142.md) | 1.01 Entry into a material agreement; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001062993-26-002142 |
| 2026-03-25 | 16:08 ET | [10-K](/filings/0001062993-26-001606.md) | Annual report, period 2025-12-31 | 0001062993-26-001606 |
| 2026-03-06 | 16:40 ET | [8-K](/filings/0001062993-26-001326.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001062993-26-001326 |
| 2025-12-30 | 09:26 ET | [8-K](/filings/0001062993-25-017492.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001062993-25-017492 |
| 2025-12-08 | 16:30 ET | [8-K](/filings/0001062993-25-017219.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001062993-25-017219 |
| 2025-12-01 | 08:13 ET | [8-K](/filings/0001062993-25-017085.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001062993-25-017085 |
| 2025-11-19 | 17:00 ET | [S-1](/filings/0001062993-25-016962.md) | Registration statement | 0001062993-25-016962 |
| 2025-11-14 | 17:17 ET | [8-K](/filings/0001062993-25-016864.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-016864 |
| 2025-11-14 | 16:02 ET | [10-Q](/filings/0001062993-25-016838.md) | Quarterly report, period 2025-09-30 | 0001062993-25-016838 |
| 2025-10-17 | 16:30 ET | [8-K](/filings/0001062993-25-016179.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001062993-25-016179 |
| 2025-09-29 | 17:08 ET | [S-1](/filings/0001062993-25-015841.md) | Registration statement | 0001062993-25-015841 |
| 2025-09-29 | 17:04 ET | [S-1](/filings/0001062993-25-015839.md) | Registration statement | 0001062993-25-015839 |
| 2025-09-18 | 08:00 ET | [8-K](/filings/0001062993-25-015700.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-015700 |
| 2025-09-12 | 17:05 ET | [8-K](/filings/0001062993-25-015601.md) | 5.02 Departure or appointment of officers or directors | 0001062993-25-015601 |
| 2025-09-02 | 14:15 ET | [8-K](/filings/0001062993-25-015149.md) | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-015149 |
| 2025-08-22 | 16:31 ET | [8-K](/filings/0001062993-25-014806.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-014806 |
| 2025-08-11 | 16:24 ET | [10-Q](/filings/0001062993-25-014058.md) | Quarterly report, period 2025-06-30 | 0001062993-25-014058 |
| 2025-08-04 | 07:36 ET | [8-K](/filings/0001062993-25-013468.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-013468 |
| 2025-07-30 | 06:57 ET | [8-K](/filings/0001062993-25-013266.md) | 8.01 Other events | 0001062993-25-013266 |
| 2025-07-23 | 08:22 ET | [8-K](/filings/0001062993-25-013073.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-013073 |
| 2025-07-14 | 08:58 ET | [8-K](/filings/0001062993-25-012767.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001062993-25-012767 |
| 2025-07-03 | 15:14 ET | [8-K/A](/filings/0001062993-25-012533.md) | 9.01 Financial statements and exhibits | 0001062993-25-012533 |
| 2025-06-30 | 16:30 ET | [DEF 14A](/filings/0001062993-25-012273.md) | Proxy statement, period 2025-07-22 | 0001062993-25-012273 |
| 2025-06-30 | 13:51 ET | [8-K](/filings/0001062993-25-012231.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-012231 |
| 2025-06-23 | 16:37 ET | [8-K](/filings/0001062993-25-012044.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-012044 |
| 2025-06-20 | 16:20 ET | [8-K](/filings/0001062993-25-011991.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001062993-25-011991 |
| 2025-06-05 | 16:05 ET | [8-K](/filings/0001062993-25-011051.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001062993-25-011051 |
| 2025-06-02 | 16:58 ET | [8-K](/filings/0001062993-25-010687.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-010687 |
| 2025-05-27 | 16:55 ET | [S-1](/filings/0001062993-25-010394.md) | Registration statement | 0001062993-25-010394 |
| 2025-05-27 | 13:16 ET | [S-1](/filings/0001062993-25-010333.md) | Registration statement | 0001062993-25-010333 |
| 2025-05-12 | 17:22 ET | [10-Q](/filings/0001062993-25-009125.md) | Quarterly report, period 2025-03-31 | 0001062993-25-009125 |
| 2025-05-05 | 09:00 ET | [8-K](/filings/0001062993-25-008436.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001062993-25-008436 |
| 2025-04-30 | 14:24 ET | [10-K/A](/filings/0001062993-25-008246.md) | Annual report, amended, period 2024-12-31 | 0001062993-25-008246 |
| 2025-04-28 | 09:25 ET | [8-K](/filings/0001062993-25-008086.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-008086 |
| 2025-03-28 | 16:02 ET | [10-K](/filings/0001062993-25-006485.md) | Annual report, period 2024-12-31 | 0001062993-25-006485 |
| 2025-03-25 | 20:06 ET | [8-K](/filings/0001062993-25-006170.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-006170 |

Page 1 of 2. [Older](/companies/mdcx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:24 ET. No prices; not investment advice.